Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 1.00 |
| ▸ | RXRB | P28702 | 1/20 | 1.00 |
| ▸ | RXRG | P48443 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | PDK1 | Q15118 | 2/20 | 0.50 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.50 |
| ▸ | PDK3 | Q15120 | 2/20 | 0.50 |
| ▸ | PDK4 | Q16654 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.50 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.50 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopimaric Acid SCHEMBL234276 | 1.00 | RXRA (1.00) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| Isopimaric Acid SCHEMBL13702083 | 1.00 | RXRA (1.00) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| Isopimaric Acid SCHEMBL15339339 | 1.00 | RXRA (1.00) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| Isopimaric Acid SCHEMBL2603438 | 1.00 | RXRA (1.00) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| Isopimaric Acid SCHEMBL15744757 | 1.00 | RXRA (1.00) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| Isopimaric Acid SCHEMBL12732275 | 1.00 | RXRA (1.00) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| Isopimaric Acid SCHEMBL15744755 | 1.00 | RXRA (1.00) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| Sandaracopimaric Acid SCHEMBL3894069 | 0.89 | RXRA (0.80) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| SCHEMBL31390163 | 0.88 | RXRA (0.78) | RXRARXRBRXRGCYP2C9CYP2C19 | |
| SCHEMBL17891641 | 0.87 | RXRA (0.77) | RXRARXRBRXRGCYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11802099-B2 | Or relating to energetic materials | LEWTAS SCIENCE & TECHNOLOGIES LTD (GB) | 2023-10-31 | — | — | US | disclosed |
| US-11802099-B2 | Or relating to energetic materials | LEWTAS SCIENCE & TECHNOLOGIES LTD (GB) | 2023-10-31 | — | — | US | disclosed |
| US-20220195348-A1 | TREATMENT COMPOSITIONS COMPRISING PLANT ROSIN MATERIAL AND CERTAIN PERFUME RAW MATERIALS | THE PROCTER & GAMBLE COMPANY | 2022-06-23 | — | — | US | disclosed |
| US-20220186147-A1 | LIQUID TREATMENT COMPOSITIONS COMPRISING DELIVERY PARTICLES BASED ON PLANT ROSIN MATERIAL | THE PROCTER & GAMBLE COMPANY | 2022-06-16 | — | — | US | disclosed |
| US-20220186149-A1 | TREATMENT COMPOSITIONS COMPRISING CERTAIN PLANT ROSIN MATERIALS | THE PROCTER & GAMBLE COMPANY | 2022-06-16 | — | — | US | disclosed |
| US-20220186148-A1 | PROCESS OF MAKING A TREATMENT COMPOSITION THAT INCLUDES A PLANT ROSIN MATERIAL AND RELATED PREMIX COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2022-06-16 | — | — | US | disclosed |
| US-20200148609-A1 | IMPROVEMENTS IN OR RELATING TO ENERGETIC MATERIALS | LEWTAS SCIENCE & TECHNOLOGIES LTD (GB) | 2020-05-14 | — | — | US | disclosed |
| US-10442955-B2 | Resin, composition and use | DSM IP ASSETS B.V. (NL) | 2019-10-15 | — | — | US | disclosed |
| EP-3367170-B1 | TONER COMPOSITIONS | XEROX CORP (US) | 2019-09-25 | — | — | EP | disclosed |
| US-20180142121-A1 | RESIN, COMPOSITION AND USE | COVESTRO (NETHERLANDS) B.V. (NL) | 2018-05-24 | — | — | US | disclosed |
| US-20120183896-A1 | Rosin-Based Resin and Toner Containing Same | XEROX CORPORATION (US) | 2012-07-19 | — | — | US | disclosed |
| US-20120114715-A1 | USE OF LARCH WOOD FOR TREATING INFLAMMATION | Aristotle University of Thessalokiki (GR) | 2012-05-10 | — | — | US | disclosed |
| US-20120114715-A1 | USE OF LARCH WOOD FOR TREATING INFLAMMATION | Aristotle University of Thessalokiki (GR) | 2012-05-10 | — | — | US | disclosed |
| US-20110269867-A1 | ALKALI-SOLUBLE POLYMER COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION USING THE SAME | LG CHEM. LTD. (KR) | 2011-11-03 | — | — | US | disclosed |
| US-20110269867-A1 | ALKALI-SOLUBLE POLYMER COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION USING THE SAME | LG CHEM. LTD. (KR) | 2011-11-03 | — | — | US | disclosed |
| US-20110135922-A1 | Adhesive Compositions with Multiple Tackifiers | 3M INNOVATIVE PROPERTIES COMPANY | 2011-06-09 | — | — | US | disclosed |
| US-20110135922-A1 | Adhesive Compositions with Multiple Tackifiers | 3M INNOVATIVE PROPERTIES COMPANY | 2011-06-09 | — | — | US | disclosed |
| US-20110045083-A1 | USE LARCH WOOD FOR TREATING INFLAMMATION | ARISTOTLE UNIVERSITY OF THESSALONIKI (GR) | 2011-02-24 | — | — | US | disclosed |
| US-20110045083-A1 | USE LARCH WOOD FOR TREATING INFLAMMATION | ARISTOTLE UNIVERSITY OF THESSALONIKI (GR) | 2011-02-24 | — | — | US | disclosed |
| WO-2009146227-A1 | ADHESIVE COMPOSITIONS WITH MULTIPLE TACKIFIERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120114715-A1 | USE OF LARCH WOOD FOR TREATING INFLAMMATION | LARP1, LARP7, TNF | RXRA 2300/4885RXRB 2892/4885RXRG 2310/4885 |
| US-20110045083-A1 | USE LARCH WOOD FOR TREATING INFLAMMATION | LARP1, LARP7, TNF | RXRA 1970/4885RXRB 2591/4885RXRG 2075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.